Success Metrics

Clinical Success Rate
83.1%

Based on 74 completed trials

Completion Rate
83%(74/89)
Active Trials
10(8%)
Results Posted
49%(36 trials)
Terminated
15(12%)

Phase Distribution

Ph early_phase_1
2
2%
Ph phase_3
17
13%
Ph phase_1
15
12%
Ph phase_2
26
20%
Ph not_applicable
26
20%
Ph phase_4
40
31%

Phase Distribution

17

Early Stage

26

Mid Stage

57

Late Stage

Phase Distribution126 total trials
Early Phase 1First-in-human
2(1.6%)
Phase 1Safety & dosage
15(11.9%)
Phase 2Efficacy & side effects
26(20.6%)
Phase 3Large-scale testing
17(13.5%)
Phase 4Post-market surveillance
40(31.7%)
N/ANon-phased studies
26(20.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

74.0%

74 of 100 finished

Non-Completion Rate

26.0%

26 ended early

Currently Active

10

trials recruiting

Total Trials

130

all time

Status Distribution
Active(12)
Completed(74)
Terminated(26)
Other(18)

Detailed Status

Completed74
unknown16
Terminated15
Withdrawn11
Active, not recruiting5
Recruiting5

Development Timeline

Analytics

Development Status

Total Trials
130
Active
10
Success Rate
83.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.6%)
Phase 115 (11.9%)
Phase 226 (20.6%)
Phase 317 (13.5%)
Phase 440 (31.7%)
N/A26 (20.6%)

Trials by Status

unknown1612%
terminated1512%
active_not_recruiting54%
recruiting54%
withdrawn118%
not_yet_recruiting22%
suspended22%
completed7457%

Recent Activity

Clinical Trials (130)

Showing 20 of 130 trialsScroll for more
NCT07567495Phase 4

Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery

Not Yet Recruiting
NCT03121261Phase 4

The Effect of Local Anesthetic and Clonidine on the Cutaneous Silent Period During Spinal Anesthesia

Active Not Recruiting
NCT07360301Phase 1

Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study

Not Yet Recruiting
NCT06049797

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

Active Not Recruiting
NCT01530373Phase 2

Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

Recruiting
NCT07313371Phase 4

Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder

Recruiting
NCT03725930Phase 3

Premedication by Clonidine Intranasal in Pediatric Surgery

Completed
NCT00262470Phase 1

Treatment of Orthostatic Intolerance

Active Not Recruiting
NCT03552068Phase 2

Study of Clonidine Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease:

Completed
NCT06287151Not Applicable

Regional Anesthesia EMG Study

Active Not Recruiting
NCT05360953Phase 2

Treating Nightmares in Posttraumatic Stress Disorder With Clonidine and Doxazosin

Suspended
NCT04423627Early Phase 1

Sympathetic Regulation of Large Artery Stiffness in Humans With ISH

Completed
NCT04828226Phase 4

Clonidine to Prevent Delirium After Electroconvulsive Therapy.

Recruiting
NCT03396588Phase 3

Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain

Completed
NCT05592379Phase 1

Consciousness, Psilocybin, and Well-Being

Completed
NCT05487196Phase 2

Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia

Completed
NCT03092011Phase 4

Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy

Active Not Recruiting
NCT03653832Phase 3

Alpha 2 Agonists for Sedation to Produce Better Outcomes From Critical Illness (A2B Trial)

Completed
NCT05560230Phase 4

Intraoperative Clonidine for Postoperative Pain Management in Patients Undergoing Surgical Treatment for Endometriosis

Completed
NCT04786873Phase 3

A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is

Completed

Drug Details

Intervention Type
DRUG
Total Trials
130